Volume 26, Issue 1 e12491
REVIEW ARTICLE

Update regarding xenotransplantation in Japan

Masayuki Shimoda

Corresponding Author

Masayuki Shimoda

Islet Cell Transplantation Project, Diabetes Research Center, Research Institute of National Center for Global Health and Medicine, Tokyo, Japan

Correspondence

Masayuki Shimoda, Islet Cell Transplantation Project, Diabetes Research Center, Research Institute of National Center for Global Health and Medicine, Tokyo, Japan.

Email: [email protected]

Search for more papers by this author
Shinichi Matsumoto

Shinichi Matsumoto

Islet Cell Transplantation Project, Diabetes Research Center, Research Institute of National Center for Global Health and Medicine, Tokyo, Japan

Search for more papers by this author
First published: 22 January 2019
Citations: 11

Abstract

To overcome the donor shortage, a promising solution could be xenotransplantation. The pig is generally considered the most suitable donor species for xenotransplantation. A clinical xenotransplantation has not been conducted in Japan. However, many progresses have recently been made in this field. Japan has regulations for conducting cell xenotransplantation and guidelines to prevent zoonosis. Most Japanese patients and their family members have a positive opinion about islet xenotransplantation. A grant for clinical islet xenotransplantation research and development has been approved, and germ-free pigs have been developed. Further research may bring the successful application of xenotransplantation closer to reality.

CONFLICT OF INTEREST

Shinichi Matsumoto is Chief Scientific Advisor of Otsuka Pharmaceutical Factory Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.